As filed with the Securities and Exchange Commission on December 19, 2012
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AbbVie Inc.
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
32-0375147 (I.R.S. Employer Identification No.) |
1 North Waukegan Road
North Chicago, Illinois 60064
(Address, including zip code, and telephone number, including
area code, of principal executive offices)
ABBVIE 2013 INCENTIVE STOCK PROGRAM
(Full title of the plan)
Laura J. Schumacher, Esq.
Executive Vice President, Business Development
and External Affairs and General Counsel
1 North Waukegan Road
North Chicago, Illinois 60064
(Name and address of agent for service)
Telephone number, including area code, of agent for service: (847) 932-7900
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer o | Accelerated filer o | Non-accelerated filer ý (Do not check if a smaller reporting company) |
Smaller reporting company o |
CALCULATION OF REGISTRATION FEE
|
||||||||
Title of securities to be registered |
Amount to be registered(1) |
Proposed maximum offering price per share(2) |
Proposed maximum aggregate offering price(2) |
Amount of registration fee(2) |
||||
---|---|---|---|---|---|---|---|---|
Common Stock, par value $0.01 |
84,000,000 | $33.34 | $2,800,560,000 | $381,996.38 | ||||
|
This Registration Statement on Form S-8 is being filed for the purpose of registering 84,000,000 shares of common stock, par value $0.01 per share, of AbbVie Inc. issuable pursuant to the AbbVie 2013 Incentive Stock Program.
Information required by Part I to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428(b)(1) under the Securities Act, and the introductory note to Part I of Form S-8. The documents containing the information specified in Part I have been or will be delivered to the participants in the Plan as required by Rule 428(b).
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.
The following documents, which have been filed by the Registrant with the Securities and Exchange Commission, referred to as the Commission, are incorporated herein by reference:
All documents filed by the Registrant with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of this Registration Statement (other than any such documents or portions thereof that are furnished under Item 2.02 or Item 7.01 of a Current Report on Form 8-K, unless otherwise indicated therein, including any exhibits included with such Items), prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents.
Any statement contained in this Registration Statement or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained or incorporated by reference herein or in any subsequently filed document which is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
ITEM 4. DESCRIPTION OF SECURITIES.
Not applicable.
ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL.
Not applicable.
2
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
The Registrant is incorporated under the laws of the State of Delaware.
Delaware law provides that directors of a corporation will not be personally liable to the corporation or its stockholders for monetary damages for breach of their fiduciary duties as directors, except for liability:
The limitation of liability does not apply to liabilities arising under the federal or state securities laws and does not affect the availability of equitable remedies, such as injunctive relief or rescission.
The Registrant's amended and restated certificate of incorporation and by-laws include provisions that indemnify, to the fullest extent allowable under the DGCL, the personal liability of directors or officers for monetary damages for actions taken as a director or officer of the Registrant, or for serving at the Registrant's request as a director or officer or another position at another corporation or enterprise, as the case may be. The Registrant's amended and restated certificate of incorporation and by-laws also provide that the Registrant must indemnify and advance reasonable expenses to its directors and officers, subject to its receipt of an undertaking from the indemnified party as may be required under the DGCL. The Registrant's amended and restated certificate of incorporation expressly authorizes the Registrant to carry directors' and officers' insurance to protect it, its directors, officers and certain employees for some liabilities.
The foregoing is only a general summary of certain aspects of Delaware law and the Registrant's certificate of incorporation and by-laws dealing with indemnification of directors and officers and does not purport to be complete. It is qualified in its entirety by reference to the detailed provisions of those sections of the DGCL referenced above and the certificate of incorporation and by-laws of the Registrant.
ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED.
Not applicable.
The list of exhibits is set forth under "Exhibit Index" at the end of this Registration Statement and is incorporated herein by reference.
3
individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement; and
provided, however, that the undertakings set forth in paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.
4
The Registrant. Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in North Chicago, Illinois, on December 19, 2012.
ABBVIE INC. | ||||||
By: |
/s/ RICHARD A. GONZALEZ |
|||||
Name: | Richard A. Gonzalez | |||||
Title: | Chairman of the Board and Chief Executive Officer |
Each person whose signature appears below constitutes and appoints Richard A. Gonzalez and Laura J. Schumacher, Esq., and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including all pre-effective and post-effective amendments and registration statements filed pursuant to Rule 462 under the Securities Act of 1933), and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in their said capacities on December 19, 2012:
Signature
|
Title
|
Date
|
||
---|---|---|---|---|
/s/ RICHARD A. GONZALEZ Richard A. Gonzalez |
Chief Executive Officer and Chairman of the Board (Principal Executive Officer) | December 19, 2012 | ||
/s/ WILLIAM J. CHASE William J. Chase |
Executive Vice President, Chief Financial Officer (Principal Financial Officer) |
December 19, 2012 |
||
/s/ THOMAS A. HURWICH Thomas A. Hurwich |
Vice President, Controller and Principal Accounting Officer |
December 19, 2012 |
||
/s/ THOMAS C. FREYMAN Thomas C. Freyman |
Director |
December 19, 2012 |
||
/s/ GREG W. LINDER Greg W. Linder |
Director |
December 19, 2012 |
5
Exhibit Number |
Description | ||
---|---|---|---|
4.1 | Form of Amended and Restated Certificate of Incorporation of AbbVie Inc. (incorporated by reference to Exhibit 3.1 of Amendment No. 6 to the Company's Registration Statement on Form 10 filed on November 30, 2012, File No. 001-35565). | ||
4.2 |
Form of Amended and Restated By-Laws of AbbVie Inc. (incorporated by reference to Exhibit 3.2 of Amendment No. 6 to the Company's Registration Statement on Form 10 filed on November 30, 2012, File No. 001-35565). |
||
4.3 |
AbbVie 2013 Incentive Stock Program (incorporated by reference to Exhibit 10.14 of Amendment No. 6 to the Company's Registration Statement on Form 10 filed on November 30, 2012, File No. 001-35565). |
||
5.1 |
Opinion of Wachtell, Lipton, Rosen & Katz.* |
||
23.1 |
Consent of Deloitte & Touche LLP.* |
||
23.2 |
Consent of Wachtell, Lipton, Rosen & Katz (included in Exhibit 5.1).* |
6
Exhibit 5.1
Wachtell, Lipton, Rosen & Katz
MARTIN LIPTON |
STEPHANIE J. SELIGMAN |
51 WEST 52ND STREET |
DAVID C. BRYAN |
MARTIN J.E. ARMS | |
HERBERT M. WACHTELL |
JOHN F. SAVARESE |
NEW YORK, N.Y. 10019-6150 |
STEVEN A. COHEN |
GREGORY E. OSTLING | |
BERNARD W. NUSSBAUM |
SCOTT K. CHARLES |
TELEPHONE: (212) 403 -1000 |
DEBORAH L. PAUL |
DAVID B. ANDERS | |
LAWRENCE B. PEDOWITZ |
DAVID S. NEILL |
FACSIMILE: (212) 403 -2000 |
DAVID C. KARP |
ADAM J. SHAPIRO | |
PAUL VIZCARRONDO, JR. |
JODI J. SCHWARTZ |
|
RICHARD K. KIM |
NELSON O. FITTS | |
PETER C. HEIN |
ADAM O. EMMERICH |
GEORGE A. KATZ (1965-1989) |
JOSHUA R. CAMMAKER |
JEREMY L. GOLDSTEIN | |
HAROLD S. NOVIKOFF |
GEORGE T. CONWAY III |
JAMES H. FOGELSON (1967-1991) |
MARK GORDON |
JOSHUA M. HOLMES | |
KENNETH B. FORREST |
RALPH M. LEVENE |
|
JOSEPH D. LARSON |
DAVID E. SHAPIRO | |
MEYER G. KOPLOW |
RICHARD G. MASON |
OF COUNSEL |
LAWRENCE S. MAKOW |
DAMIAN G. DIDDEN | |
THEODORE N. MIRVIS |
MICHAEL J. SEGAL |
|
|
JEANNEMARIE OBRIEN |
ANTE VUCIC |
EDWARD D. HERLIHY |
DAVID M. SILK |
WILLIAM T. ALLEN |
ERIC S. ROBINSON |
WAYNE M. CARLIN |
IAN BOCZKO |
DANIEL A. NEFF |
ROBIN PANOVKA |
PETER C. CANELLOS |
PATRICIA A. ROBINSON* |
STEPHEN R. DiPRIMA |
MATTHEW M. GUEST |
ERIC M. ROTH |
DAVID A. KATZ |
DAVID M. EINHORN |
LEONARD M. ROSEN |
NICHOLAS G. DEMMO |
DAVID E. KAHAN |
ANDREW R. BROWNSTEIN |
ILENE KNABLE GOTTS |
THEODORE GEWERTZ |
MICHAEL W. SCHWARTZ |
IGOR KIRMAN |
DAVID K. LAM |
MICHAEL H. BYOWITZ |
DAVID M. MURPHY |
RICHARD D. KATCHER |
ELLIOTT V. STEIN |
JONATHAN M. MOSES |
BENJAMIN M. ROTH |
PAUL K. ROWE |
JEFFREY M. WINTNER |
THEODORE A. LEVINE |
WARREN R. STERN |
T. EIKO STANGE |
JOSHUA A. FELTMAN |
MARC WOLINSKY |
TREVOR S. NORWITZ |
DOUGLAS K. MAYER |
PATRICIA A. VLAHAKIS |
DAVID A. SCHWARTZ |
ELAINE P. GOLIN |
DAVID GRUENSTEIN |
BEN M. GERMANA |
ROBERT B. MAZUR |
J. BRYAN WHITWORTH |
JOHN F. LYNCH |
EMIL A. KLEINHAUS |
STEPHEN G. GELLMAN |
ANDREW J. NUSSBAUM |
PHILIP MINDLIN |
AMY R. WOLF |
WILLIAM SAVITT |
KARESSA L. CAIN |
STEVEN A. ROSENBLUM |
RACHELLE SILVERBERG |
ROBERT M. MORGENTHAU |
|
ERIC M. ROSOF |
|
|
|
|
|
|
|
|
|
* ADMITTED IN THE DISTRICT OF COLUMBIA |
|
| |
|
|
|
|
| |
|
|
COUNSEL |
|
| |
|
|
|
|
|
|
|
|
DAVID M. ADLERSTEIN |
PAULA N. GORDON |
|
|
|
|
MICHELE J. ALEXANDER |
NANCY B. GREENBAUM |
|
|
|
|
LOUIS J. BARASH |
MAURA R. GROSSMAN |
|
|
|
|
DIANNA CHEN |
MARK A. KOENIG |
|
|
|
|
ANDREW J.H. CHEUNG |
J. AUSTIN LYONS |
|
|
|
|
PAMELA EHRENKRANZ |
AMANDA N. PERSAUD |
|
|
|
|
KATHRYN GETTLES-ATWA |
JEFFREY A. WATIKER |
|
|
December 19, 2012
AbbVie Inc.
1 North Waukegan Road
North Chicago, IL 60064
Re: Registration Statement on Form S-8
We have acted as special counsel to AbbVie Inc., a Delaware corporation (the Company), in connection with the preparation and filing of the Companys Registration Statement on Form S-8 (the Registration Statement) relating to a total of 84,000,000 shares of the Companys common stock, par value $0.01 per share (the Common Stock), issuable upon exercise of stock options or otherwise in connection with grants of equity-based awards under the AbbVie 2013 Incentive Stock Program (the Plan) to be issued in connection with the distribution by Abbott Laboratories (Abbott) of all of the outstanding shares of the Common Stock to shareholders of Abbott (the Distribution).
In rendering this opinion, we have examined such corporate records and other documents (including the written document constituting the Plan, the Registration Statement and the Companys certificate of incorporation and by-laws as currently in effect and amendments thereto as contemplated to be in effect at the time of the Distribution), and we have reviewed such matters of law, as we have deemed necessary or appropriate. In rendering this opinion, we have, with the Companys consent, relied upon oral and written representations of officers of the Company and certificates of officers of the Company and public officials with respect to the accuracy of the factual matters addressed in such representations and certificates. In addition, in rendering this opinion we have, with the Companys consent, assumed the genuineness of all signatures or instruments relied upon by us, and the conformity of certified copies submitted to us with the original documents to which such certified copies relate. In addition, we have assumed that the Plan will be effective at the time that the Common Stock will be issued and delivered.
December 19, 2012
We are members of the Bar of the State of New York and we express no opinion as to the laws of any jurisdiction other than the federal laws of the United States, the laws of the State of New York and the General Corporation Law of the State of Delaware.
Based on the foregoing and subject to the qualifications and limitations set forth herein, we are of the opinion that upon issuance and delivery pursuant to the terms and conditions set forth in the Registration Statement, the prospectus delivered to participants in the Plan and the Plan, the Common Stock will be legally issued, fully paid and nonassessable.
We hereby consent to be named in the Registration Statement and in the related prospectus contained therein as the attorneys who passed upon the legality of the Common Stock and to the filing of a copy of this opinion as Exhibit 5.1 to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended. We assume no obligation to advise you or any other person, or to make any investigations, as to any legal developments or factual matters arising subsequent to the date of effectiveness of the Registration Statement that might affect the opinions expressed herein.
|
Very truly yours, |
|
|
|
/s/ Wachtell, Lipton, Rosen & Katz |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report relating to the combined financial statements of the Research-Based Pharmaceuticals Business of Abbott Laboratories (AbbVie) dated June 4, 2012, appearing in AbbVie Inc.s Registration Statement on Form 10 (Commission File No. 001-35565) for the year ended December 31, 2011.
/s/ DELOITTE & TOUCHE LLP
Chicago, Illinois
December 19, 2012